Monthly Covaxin output between 5.5-6.5 cr. Country needs at least 15 cr doses for full coverage 15-18 age group. Choice of 6 μg dose reduced manufacturing capacity, says Bharat Biotech.
Health minister Mandaviya says 1.47 crore beneficiaries in the 15-18 age group are fully vaccinated and appealed to all eligible children to get inoculated at the earliest.
To get a sense of the scope of the issue, WHO examined the fate of 87,000 metric tonnes of PPE that were shipped via a UN initiative between March 2020 and November 2021.
Covaxin makers said most reported side effects are mild & 'resolve within 1-2 days, and do not require medication'. So far Covaxin is only Covid vaccine available for 15-18 year olds in India.
PM Modi had announced on 25 December that adolescents above the age of 15 will be able to take their vaccines from 3 January. The campaign began Monday.
Earlier in the year, Cipla entered into a licensing agreement with Merck Sharpe Dohme to make and supply Molnupiravir in India and to over 100 low and middle-income countries.
Speaking at a conference Tuesday, Serum Institute of India's CEO Adar Poonawalla said the Covovax vaccine is under trial & would offer protection to children as young as 3 years.
New Delhi, Nov 16 (PTI) The National Financial Reporting Authority (NFRA) will carry out audit quality inspections of five audit firms, including the...
No matter what tactics, doctrine, or weapon system is used, the objective of any war is to control territory, argues Gen. MM Naravane (retd). But it's politics that matters most.